These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6850937)

  • 1. Influence of fatty acid composition on the properties and polymorphic transition of fatty suppository bases.
    Yoshino H; Kobayashi M; Samejima M
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):237-46. PubMed ID: 6850937
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of the liquid phase coexisting in fatty suppository bases on the polymorphic transition rate.
    Yoshino H; Kobayashi M; Samejima M
    Chem Pharm Bull (Tokyo); 1982 Aug; 30(8):2941-50. PubMed ID: 7139836
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymorphic transition rate of semisynthetic fatty suppository bases.
    Yoshino H; Kobayashi M; Samejima M
    Chem Pharm Bull (Tokyo); 1981 Sep; 29(9):2661-9. PubMed ID: 7349284
    [No Abstract]   [Full Text] [Related]  

  • 4. [The physical properties of suppository excipients analysis of texture by means of thermocouple].
    Combes A; Bos R; Michaud P; Rouffiac R
    Pharm Acta Helv; 1989; 64(11):296-300. PubMed ID: 2608687
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study on the polymorphic transition of semisynthetic triglycerides of fatty acid suppository bases].
    Xie XH; Gu XC; Liu FY
    Yao Xue Xue Bao; 1988 May; 23(5):388-93. PubMed ID: 3213521
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stability of drugs in lyophilic suppository bases. IV. Identification of decomposition products of cyclovegantine isolated from suppositories].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(1):99-107. PubMed ID: 4151652
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stability of drugs in lyophilic suppository bases. V. Identification of products of ethionamide decay isolated from suppositories].
    Cieszyński T
    Acta Pol Pharm; 1974; 31(5):651-6. PubMed ID: 4447018
    [No Abstract]   [Full Text] [Related]  

  • 8. Stabilization of AD-1590, a non-steroidal antiinflammatory agent, in suppository bases by beta-cyclodextrin complexation.
    Takahashi T; Kagami I; Kitamura K; Nakanishi Y; Imasato Y
    Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1770-4. PubMed ID: 3487392
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of two different kinds of silicium dioxide on release of drugs from suppositories: benzydamine hydrochloride.
    Dal Zotto M; Realdon N; Ragazzi E; Dalla Fini G
    Farmaco; 1991 May; 46(5):699-711. PubMed ID: 1659426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of sustained release suppositories prepared with fatty base including solid fats with high melting points.
    Takatori T; Shimono N; Higaki K; Kimura T
    Int J Pharm; 2004 Jul; 278(2):275-82. PubMed ID: 15196632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Applicability of densitometry procedures to the study of polymorphic transformation of triglyceride suppository size].
    Hüttenrauch R; Möller U
    Pharmazie; 1985 Aug; 40(8):582-3. PubMed ID: 4080812
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on pharmaceutical drug design for suppositories. II. Rheological properties of emulsion-type suppository bases.
    Noro S; Komatsu Y; Uesugi T
    Chem Pharm Bull (Tokyo); 1982 Aug; 30(8):2906-11. PubMed ID: 7139833
    [No Abstract]   [Full Text] [Related]  

  • 13. The release of naproxen in fatty suppository bases by beta-cyclodextrin complexation.
    Celebi N; Iscanoglu M; Degim T
    Pharmazie; 1991 Dec; 46(12):863-5. PubMed ID: 1818322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the action of various factors on the liberation from suppositories (author's transl)].
    Bornschein M; Grohmann A; Voigt R
    Pharmazie; 1980 Dec; 35(12):772-6. PubMed ID: 7208579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on stability of drugs in lyophilic suppository bases. 3. Isolation of cyclovegantine, ethionamide and euphyllin degradation products from suppositories.
    Cieszyński T
    Acta Pol Pharm; 1972; 29(1):75-83. PubMed ID: 5055291
    [No Abstract]   [Full Text] [Related]  

  • 16. [STUDY OF THE PHYSICAL-CHEMICAL PROPERTIES OF POLYETHYLENE OXIDES AS SUPPOSITORY BASES].
    GLUZMAN MKh; DASHEVSKAIA BI; FRIDMAN GM
    Med Prom SSSR; 1965 May; 73():16-22. PubMed ID: 14299120
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rheological study of suppository bases with special reference to their consistency].
    Regdon G; Mezey G; Regdon G
    Acta Pharm Hung; 1973 Mar; 43(2):57-66. PubMed ID: 4697143
    [No Abstract]   [Full Text] [Related]  

  • 18. [RHEOLOGICAL EXAMINATION OF SOME SUPPOSITORY BASES].
    KEDVESSY G; REGDON G; SZANTO F; GILDE FARKAS M
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1963 Dec; 33():837-44. PubMed ID: 14217980
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
    Szente L; Apostol I; Szejtli J
    Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [THE DEVELOPMENT OF RECTAL THERAPY WITH REGARD TO MODERN SUPPOSITORY BASES].
    TUMA R
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1963 Aug; 33():137-48. PubMed ID: 14118254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.